BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Claesson K, Magnander K, Kahu H, Lindegren S, Hultborn R, Elmroth K. RBE of α-particles from 211 At for complex DNA damage and cell survival in relation to cell cycle position. International Journal of Radiation Biology 2011;87:372-84. [DOI: 10.3109/09553002.2011.538127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Guérard F, Gestin JF, Brechbiel MW. Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy. Cancer Biother Radiopharm 2013;28:1-20. [PMID: 23075373 DOI: 10.1089/cbr.2012.1292] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
2 Chen Y, Kornblit B, Hamlin DK, Sale GE, Santos EB, Wilbur DS, Storer BE, Storb R, Sandmaier BM. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation. Blood 2012;119:1130-8. [PMID: 22134165 DOI: 10.1182/blood-2011-09-380436] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
3 Bannik K, Madas B, Jarzombek M, Sutter A, Siemeister G, Mumberg D, Zitzmann-Kolbe S. Radiobiological effects of the alpha emitter Ra-223 on tumor cells. Sci Rep 2019;9:18489. [PMID: 31811257 DOI: 10.1038/s41598-019-54884-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Dabagian H, Taghvaee T, Martorano P, Martinez D, Samanta M, Watkins CM, Chai R, Mansfield A, Graham TJ, Maris JM, Pryma DA, Mach RH, Makvandi M. PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma. ACS Pharmacol Transl Sci 2021;4:344-51. [PMID: 33615184 DOI: 10.1021/acsptsci.0c00206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
6 Lyckesvärd MN, Delle U, Kahu H, Lindegren S, Jensen H, Bäck T, Swanpalmer J, Elmroth K. Alpha particle induced DNA damage and repair in normal cultured thyrocytes of different proliferation status. Mutat Res 2014;765:48-56. [PMID: 24769180 DOI: 10.1016/j.mrfmmm.2014.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Moreira HM, Guerra Liberal FD, McMahon SJ, Prise KM. Characterization of a custom-made 241Am alpha-source for radiobiological studies. Appl Radiat Isot 2021;177:109931. [PMID: 34488046 DOI: 10.1016/j.apradiso.2021.109931] [Reference Citation Analysis]
8 Kodaira S, Morokoshi Y, Li HK, Konishi T, Kurano M, Hasegawa S. Evidence of Local Concentration of α-Particles from 211At-Labeled Antibodies in Liver Metastasis Tissue. J Nucl Med 2019;60:497-501. [PMID: 30291193 DOI: 10.2967/jnumed.118.216853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lomax ME, Folkes LK, O'Neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol) 2013;25:578-85. [PMID: 23849504 DOI: 10.1016/j.clon.2013.06.007] [Cited by in Crossref: 279] [Cited by in F6Publishing: 246] [Article Influence: 34.9] [Reference Citation Analysis]
10 Friedrich T, Scholz U, Elsässer T, Durante M, Scholz M. Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J Radiat Res 2013;54:494-514. [PMID: 23266948 DOI: 10.1093/jrr/rrs114] [Cited by in Crossref: 129] [Cited by in F6Publishing: 112] [Article Influence: 14.3] [Reference Citation Analysis]
11 Song H, Senthamizhchelvan S, Hobbs RF, Sgouros G. Alpha Particle Emitter Radiolabeled Antibody for Metastatic Cancer: What Can We Learn from Heavy Ion Beam Radiobiology? Antibodies 2012;1:124-48. [DOI: 10.3390/antib1020124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kodaira S, Li HK, Konishi T, Kitamura H, Kurano M, Hasegawa S. Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors. PLoS One 2017;12:e0178472. [PMID: 28658304 DOI: 10.1371/journal.pone.0178472] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Mairani A, Magro G, Dokic I, Valle SM, Tessonnier T, Galm R, Ciocca M, Parodi K, Ferrari A, Jäkel O, Haberer T, Pedroni P, Böhlen TT. Data-driven RBE parameterization for helium ion beams. Phys Med Biol 2016;61:888-905. [PMID: 26740518 DOI: 10.1088/0031-9155/61/2/888] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
14 Staaf E, Brehwens K, Haghdoost S, Pachnerová-Brabcová K, Czub J, Braziewicz J, Nievaart S, Wojcik A. Characterisation of a setup for mixed beam exposures of cells to 241Am alpha particles and X-rays. Radiat Prot Dosimetry 2012;151:570-9. [PMID: 22434924 DOI: 10.1093/rpd/ncs024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
15 Magnander K, Elmroth K. Biological consequences of formation and repair of complex DNA damage. Cancer Lett. 2012;327:90-96. [PMID: 22353687 DOI: 10.1016/j.canlet.2012.02.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]